Recommended Lung Function Tests for Bronchiectasis
According to standard guidelines, patients with bronchiectasis should undergo regular lung function monitoring including spirometry (FEV1 and FVC), sputum culture, and pulse oximetry as the core recommended tests. 1, 2
Core Lung Function Tests for Bronchiectasis
Initial Assessment
Spirometry:
Sputum Collection:
Pulse Oximetry:
Routine Monitoring Tests
The British Thoracic Society recommends the following schedule for routine monitoring based on disease severity 1:
| Test | Mild Disease | Moderate-Severe Disease |
|---|---|---|
| BMI (Body Mass Index) | Annual | Annual |
| Exacerbation History | Annual | 6 monthly |
| Sputum Culture | Annual | 6 monthly |
| MRC Dyspnoea Score | Annual | 6 monthly |
| Spirometry | Annual | Annual |
| Oxygen saturation monitoring | Annual | 6 monthly |
Additional Testing Based on Clinical Context
For Deteriorating Patients
- More frequent spirometry to track lung function decline 1
- Additional sputum cultures to identify new pathogens or antibiotic resistance 1
- Assessment for comorbidities that may be contributing to deterioration 1
Advanced Lung Function Testing
Body plethysmography:
Diffusing Capacity (DLCO):
Lung Clearance Index (LCI):
Imaging
- CT scan:
Clinical Pearls and Pitfalls
Air trapping and diffusion impairment are actually more common functional abnormalities than airflow obstruction in bronchiectasis 3
Pitfall: Relying solely on spirometry may miss significant functional abnormalities. Consider more comprehensive testing in patients with symptoms disproportionate to spirometry findings 3
Pitfall: Upper airway swabs are unreliable for predicting lower airway pathogens. Always obtain sputum samples when possible 1
Pearl: Bronchial reversibility testing should assess both FEV1 and residual volume, as RV reversibility (17.6%) is more common than FEV1 reversibility (4.3%) 3
Pearl: A baseline chest X-ray provides a useful comparator for future clinical deterioration 1
By implementing these recommended lung function tests according to established guidelines, clinicians can better monitor disease progression, detect complications early, and optimize treatment strategies for patients with bronchiectasis.